Short Interest in Movano Inc. (NASDAQ:MOVE) Declines By 21.7%

Movano Inc. (NASDAQ:MOVE) saw a large decline in short interest in the month of December. As of December 15th, there was short interest totaling 61,231 shares, a decline of 21.7% from the November 30th total of 78,152 shares. Based on an average daily trading volume, of 177,725 shares, the short-interest ratio is currently 0.3 days. Currently, 8.2% of the company’s shares are sold short. Currently, 8.2% of the company’s shares are sold short. Based on an average daily trading volume, of 177,725 shares, the short-interest ratio is currently 0.3 days.

Movano News Summary

Here are the key news stories impacting Movano this week:

• Positive Sentiment: Technical signal — shares have moved above the 200‑day moving average, which can trigger momentum buying from technical traders. Movano Share Passes Above 200-Day MA
• Neutral Sentiment: Recent quarterly print mixed — Movano reported a surprise EPS beat in November but revenue was negligible and losses were extreme; the beat may limit downside in the near term but doesn’t resolve operational concerns.
• Negative Sentiment: Low liquidity and tiny market cap amplify moves — trading volume today is far below the stock’s average and the company’s market cap is very small, increasing volatility and making sustained rallies harder to trust.
• Negative Sentiment: Short‑term technicals still weak — the share price remains below the 50‑day moving average and overall trend signals are mixed, so momentum could reverse if buyers don’t follow through.
• Negative Sentiment: Fundamental risks persist — minimal revenue and massive negative margins keep longer‑term investors skeptical; any rally may be speculative until revenue and margins improve.

Movano Trading Down 0.8%

Shares of Movano stock traded down $0.06 during trading on Tuesday, reaching $7.91. The stock had a trading volume of 20,685 shares, compared to its average volume of 293,520. The company has a market capitalization of $6.57 million, a price-to-earnings ratio of -0.73 and a beta of 0.76. Movano has a 52 week low of $4.67 and a 52 week high of $59.90. The stock has a fifty day moving average price of $8.57 and a two-hundred day moving average price of $7.51.

Movano (NASDAQ:MOVE) last announced its earnings results on Friday, November 14th. The technology company reported ($4.73) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($7.00) by $2.27. Movano had a negative return on equity of 647.91% and a negative net margin of 3,409.60%.The business had revenue of $0.08 million for the quarter, compared to analyst estimates of $3.88 million.

Wall Street Analyst Weigh In

Several analysts recently commented on the company. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Movano in a research note on Wednesday, October 8th. Wall Street Zen upgraded Movano to a “hold” rating in a report on Saturday, December 20th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company currently has a consensus rating of “Sell”.

Institutional Investors Weigh In On Movano

A hedge fund recently raised its stake in Movano stock. Baird Financial Group Inc. grew its holdings in shares of Movano Inc. (NASDAQ:MOVE) by 3.6% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 323,943 shares of the technology company’s stock after buying an additional 11,366 shares during the quarter. Baird Financial Group Inc. owned approximately 4.60% of Movano worth $593,000 at the end of the most recent reporting period. Institutional investors own 16.64% of the company’s stock.

About Movano

Movano Health, Inc (NASDAQ: MOVE) is a health technology company focused on developing wearable devices for continuous biometric monitoring. The company’s core mission is to provide accessible, real-time health insights through noninvasive sensors, enabling individuals and care teams to track vital signs and physiological trends outside of traditional clinical settings.

Movano’s flagship product is a biometric monitoring ring designed to measure parameters such as heart rate, blood oxygen saturation, skin temperature, and sleep quality.